Stock Scorecard



Stock Summary for Nautilus Biotechnology Inc (NAUT) - $2.34 as of 4/18/2024 10:07:48 PM EST

Total Score

10 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for NAUT

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for NAUT

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for NAUT

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for NAUT

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for NAUT

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024 4/11/2024 12:00:00 PM
SkyWater Technology ( SKYT ) Q4 2023 Earnings Call Transcript 2/27/2024 1:30:00 AM
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference 2/22/2024 1:00:00 PM
Nautilus Biotechnology Reports Third Quarter 2023 Financial Results 10/31/2023 12:05:00 PM
Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023 10/11/2023 12:05:00 PM
Williams-Sonoma, ESS Tech And Other Big Stocks Moving Higher On Monday - AMC Enter Hldgs ( NYSE:AMC ) , Canopy Gwth ( NASDAQ:CGC ) 9/25/2023 2:45:00 PM
World Leaders in Proteomics and Genomics to Convene at the 2nd International Top-Down Proteomics Symposium 9/20/2023 3:11:00 PM
Farfetch, Faraday Future Intelligent Electric, VinFast And Other Stocks Moving Lower On Friday - Beneficient ( NASDAQ:BENF ) , Faraday Future ( NASDAQ:FFIE ) 8/18/2023 3:46:00 PM
US Stocks Sink; Deere Shares Fall Despite Earnings Beat - Deere ( NYSE:DE ) , Meta Data ( NYSE:AIU ) 8/18/2023 3:08:00 PM
Nautilus Biotechnology Reports Second Quarter 2023 Financial Results 8/2/2023 11:30:00 AM

Financial Details for NAUT

Company Overview

Ticker NAUT
Company Name Nautilus Biotechnology Inc
Country USA
Description Nautilus Biotechnology, Inc., a development-stage life sciences company, is dedicated to creating platform technology to quantify and unlock proteome complexity. The company is headquartered in Seattle, Washington.
Sector Name REAL ESTATE & CONSTRUCTION
Industry Name BLANK CHECKS
Most Recent Quarter 12/31/2023
Next Earnings Date 4/30/2024

Stock Price History

Last Day Price 2.34
Last Day Price Updated 4/18/2024 10:07:48 PM EST
Last Day Volume 99,733
Average Daily Volume 83,224
52-Week High 4.65
52-Week Low 2.16
Last Price to 52 Week Low 8.33%

Valuation Measures

Trailing PE N/A
Industry PE 86.70
Sector PE 63.90
5-Year Average PE -4.03
Free Cash Flow Ratio 1.68
Industry Free Cash Flow Ratio 278.80
Sector Free Cash Flow Ratio 173.85
Current Ratio Most Recent Quarter 19.39
Total Cash Per Share 1.39
Book Value Per Share Most Recent Quarter 2.12
Price to Book Ratio 1.17
Industry Price to Book Ratio 3.05
Sector Price to Book Ratio 3.51
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 0.54
Sector Price to Sales Ratio Twelve Trailing Months 3.44

Share Statistics

Total Shares Outstanding 125,098,000
Market Capitalization 292,729,320
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -9.93%
Reported EPS 12 Trailing Months -0.51
Reported EPS Past Year 0.00
Reported EPS Prior Year -0.52
Net Income Twelve Trailing Months -63,675,000
Net Income Past Year -63,675,000
Net Income Prior Year -57,924,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%

Balance Sheet

Total Cash Most Recent Quarter 173,400,000
Total Cash Past Year 173,400,000
Total Cash Prior Year 184,500,000
Net Cash Position Most Recent Quarter 173,400,000
Net Cash Position Past Year 173,400,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 265,353,000
Total Stockholder Equity Prior Year 314,924,000
Total Stockholder Equity Most Recent Quarter 265,353,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.06
MACD Signal -0.04
20-Day Bollinger Lower Band 2.38
20-Day Bollinger Middle Band 2.86
20-Day Bollinger Upper Band 3.34
Beta 1.00
RSI 42.10
50-Day SMA 2.99
200-Day SMA 0.00

System

Modified 4/18/2024 6:37:28 AM EST